论文信息 - Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms - 字舞流文

Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms

N. Bishop | N. Brunskill | K. Hull | J. Burton | E. J. Carr | R. Beale | M. Graham-Brown | R. Baines | P. Bird | D. March | R. Billany | H. Selvaskandan | Sherna F. Adenwalla | Julian W. Tang | Chris W. Holmes

[1] D. Segev,et al. Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients. , 2021, JAMA.

[2] H. Sakhi,et al. Kinetics of Anti–SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection , 2021, Journal of the American Society of Nephrology : JASN.

[3] Jonathan C. Brown,et al. Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine , 2021, The Lancet.

[4] M. Hernán,et al. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting , 2021, The New England journal of medicine.

[5] A. Kshirsagar,et al. Systematic Review of Safety and Efficacy of COVID-19 Vaccines in Patients With Kidney Disease , 2021, Kidney International Reports.

[6] Nguyen H. Tran,et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials , 2021, The Lancet.

[7] K. Bhaskaran,et al. OpenSAFELY: factors associated with COVID-19 death in 17 million patients , 2020, Nature.

[8] K. Bhaskaran,et al. Factors associated with COVID-19-related death using OpenSAFELY , 2020, Nature.

[9] Y. Yuzawa,et al. Aspects of immune dysfunction in end-stage renal disease. , 2008, Clinical journal of the American Society of Nephrology : CJASN.